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Any researcher needs to ensure that research follows high ethical standards. Otherwise, the research proposal may be defeated by just one vote of ethical issues. During the recent two decades, clinical research has been progressing rapidly in China. At the same time, China has made steady progress to strengthen the protection of human research participants. However, compared with U.S. regulations for protecting human subjects, there are still many issues to improve, especially for vulnerable participants, such as children and patients with mental disorders. As author mentioned in "A Brief introduction to Institutional Review Boards (IRB) in the United States",[1](#ped412024-bib-0001){ref-type="ref"} it is necessary for Chinese investigators and ethics committees to become familiar with the U.S. regulations for protecting human subjects. On the other hand, international research is important to close the "10/90 gap" in health research, i.e. 90% of the global burden of disease receives only 10% of global research investment.[2](#ped412024-bib-0002){ref-type="ref"} Underdeveloped countries can benefit from involving in international researches, including addressing the enormous health problems in locals, and building local capacity of research. However, particular risks for violations of human subject protections may occur in international researches. In this case, the ethical concerns will be violated if IRB systems for ethical review of research in underdeveloped countries are poor. Therefore, it is also justice for researchers involving in international research to fully learn about the U.S. regulations for protecting human subjects.

Another point needed to emphasize is to protect the interests of children regardless in clinical research or clinical practicet because children are vulnerable participants.[3](#ped412024-bib-0003){ref-type="ref"} For pediatric research, the IRB in USA must determine if the research with children is involving more than minimal risk (45CFR46.111).[4](#ped412024-bib-0004){ref-type="ref"} In china, Center for Drug Evaluation, SDA (state food and drug administration) issued "Technical Guidelines for Clinical Trial of Drugs in Pediatrics" in 2016, in which principles for pediatric participants include the minimal sample size, the least specimens, and the minimal hurt.[5](#ped412024-bib-0005){ref-type="ref"} However, what is not optimistic is that many pediatric researchers are limited in competency in ethics.[6](#ped412024-bib-0006){ref-type="ref"} Therefore, education on ethics in clinical research should be strengthened which can protect research participants by adhering to principle of respect for persons, beneficence and justice, as well as can prepare residents to successfully handle the conflicts occurred in clinical research or clinical practice. Be sure, IRB approval is not a one‐time event rather an ongoing process.
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